Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;18(1):15-23.
doi: 10.1007/s13770-020-00306-z. Epub 2020 Nov 4.

Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application

Affiliations
Review

Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application

Hue Thi Hong Bui et al. Tissue Eng Regen Med. 2021 Feb.

Abstract

Mesenchymal stem/stromal cells (MSCs) are multipotent somatic stem/progenitor cells that can be isolated from various tissues and have attracted increasing attention from the scientific community. This is due to MSCs showing great potential for incurable disease treatment, and most applications of MSCs involve tissue degeneration and treatment of immune- and inflammation-mediated diseases. Conventional MSC cultures contain fetal bovine serum (FBS), which is a common supplement for cell development but is also a risk factor for exposure to animal-derived pathogens. To avoid the risks resulting from the xenogeneic origin and animal-derived pathogens of FBS, xeno-free media have been developed and commercialized to satisfy MSC expansion demands for human clinical applications. This review summarized and provided an overview of xeno-free media that are currently used for MSC expansion. Additionally, we discussed the influences of different xeno-free media on MSC biology with particular regard to cell morphology, surface marker expression, proliferation, differentiation and immunomodulation. The xeno-free media can be serum-free and xeno-free media or media supplemented with some human-originating substances, such as human serum, human platelet lysates, human umbilical cord serum/plasma, or human plasma-derived supplements for cell culture medium. These media have capacity to maintain a spindle-shaped morphology, the expression of typical surface markers, and the capacity of multipotent differentiation and immunomodulation of MSCs. Xeno-free media showed potential for safe use for human clinical treatment. However, the influences of these xeno-free media on MSCs are various and any xeno-free medium should be examined prior to being used for MSC cultures.

Keywords: Clinical application; Mesenchymal stem cells; Xeno-free and serum-free media; Xeno-free media.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to declare.

Figures

Fig. 1
Fig. 1
Population doubling times (PDT) of MSCs cultured in xeno-free media normalized to FBS-supplemented media. Xeno-free media including hUCS-supplemented media and XF/SFM media expressed a higher capacity to support MSC proliferation than FBS-supplemented media (lower than 1), whereas SCC-supplemented media expressed a lower capacity to support MSC proliferation (higher than 1). The HS-supplemented media are various where different studies expressed different capacity to enhance MSC proliferation. Data was analyzed by GraphPad Prism 8 software. MesenCult™-XF Medium is represented for XF/SFM media. Black triangle (formula image ) indicates PDT of MSCs cultured in HS; black square (■) indicates PDT of MSCs cultured in HPL; black and white triangle (formula image ) indicates PDT of MSCs cultured in hUCS; black and white square (formula image ) indicates PDT of MSCs cultured in SCC; black diamond (◆) indicates PDT of MSCs cultured in XF/SFM

Similar articles

Cited by

References

    1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393–403. - PubMed
    1. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8:886. doi: 10.3390/cells8080886. - DOI - PMC - PubMed
    1. Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22. doi: 10.1038/s41536-019-0083-6. - DOI - PMC - PubMed
    1. Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12. doi: 10.1186/1478-811X-9-12. - DOI - PMC - PubMed
    1. Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191. doi: 10.3389/fimmu.2019.01191. - DOI - PMC - PubMed

LinkOut - more resources